Sponsor:
Massachusetts General Hospital
Code:
NCT05747534
Conditions
Long COVID
Long COVID-19
Post Acute COVID-19 Syndrome
Post Acute Sequelae of COVID-19
Eligibility Criteria
Sex: All
Age: 7 - 50
Healthy Volunteers: Not accepted
Interventions
Larazotide Acetate
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-08. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2025-01-23.